Risks and benefits of screening asymptomatic women for ovarian cancer: A systematic review and meta-analysis

Gynecologic Oncology

Volumn 130, Issue 3, 2013, Pages 674-681

  Reade, Clare J ^a,b   Riva, John J ^b   Busse, Jason W ^b   Goldsmith, Charlie H ^b,c,d   Elit, Laurie ^b,e  

^a UNIVERSITY OF TORONTO   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c SIMON FRASER UNIVERSITY   (Canada)

^d ARTHRITIS RESEARCH CENTRE OF CANADA   (Canada)

^e JURAVINSKI CANCER CENTRE   (Canada)

Author keywords

CA 125; Harm; Ovarian cancer; Screening; Systematic review; Transvaginal ultrasound

Indexed keywords

ADVANCED CANCER; ARTICLE; CANCER MORTALITY; CANCER SCREENING; DISTRESS SYNDROME; FALSE POSITIVE RESULT; HUMAN; META ANALYSIS; OVARY CANCER; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; QUALITY OF LIFE; RISK FACTOR; SHORT FORM 12; SHORT FORM 36; SYSTEMATIC REVIEW; TRANSVAGINAL ECHOGRAPHY;

EID: 84882451638     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2013.06.029     Document Type: Review

References (48)

1. N. Howlader, A. Noone, M. Krapcho, N. Neyman, R. Aminou, and W. Waldron SEER Cancer Statistics Review, 1975-2008 2011 National Cancer Institute Bethesda, MD
2. R. Bell, M. Petticrew, and T. Sheldon The performance of screening tests for ovarian cancer: results of a systematic review Br J Obstet Gynaecol 105 1998 1136 1147
3. R.J. Kurman, K. Visvanathan, R. Roden, T.C. Wu, and Ie M. Shih Early detection and treatment of ovarian cancer: shifting from early stage to minimal volume of disease based on a new model of carcinogenesis Am J Obstet Gynecol 198 2008 351 356
4. M. Fung Kee Fung, P. Bryson, M. Johnston, and A. Chambers Screening postmenopausal women for ovarian cancer: a systematic review J Obstet Gynaecol Can 26 2004 717 728
5. S.S. Buys, E. Partridge, A. Black, C.C. Johnson, L. Lamerato, and C. Isaacs Effect of screening on ovarian cancer mortality: the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening randomized controlled trial JAMA 305 2011 2295 2303
6. M.F.K. Fung, P. Bryson, M. Johnston, and A. Chambers Group motGCDS. Screening postmenopausal women for ovarian cancer: evidence summary report # 4-6a Cancer Care Ont 2004 1 26
7. US. Preventive Services Task Force Screening for ovarian cancer 2004 USPSTF Program Office
8. ACOG Committee on Gynecologic Practice ACOG Committee opinion no. 356: routine cancer screening Obstet Gynecol 108 2006 1611 1613
9. C. Gladstone Screening for ovarian cancer Canadian Task Force on the Periodic Health Examination: Canadian Guide to Clinical Preventive Health Care 1994 Health Canada Ottawa, Ontario, Canada 870 881
10. M. Barton, and K. Lin Screening for ovarian cancer: evidence update for the U.S. Preventive Services Task Force reaffirmation recommendation statement 2012 U.S. Preventive Services Task Force
11. L.M. Baldwin, K.F. Trivers, B. Matthews, C.H. Andrilla, J.W. Miller, and D.L. Berry Vignette-based study of ovarian cancer screening: do U.S. physicians report adhering to evidence-based recommendations? Ann Intern Med 156 2012 182 194
12. R.A. Stewart, J. Thistlethwaite, and R. Evans Pelvic examination of asymptomatic women - attitudes and clinical practice Aust Fam Physician 37 2008 493 496
13. H. Kobayashi, Y. Yamada, T. Sado, M. Sakata, S. Yoshida, and R. Kawaguchi A randomized study of screening for ovarian cancer: a multicenter study in Japan Int J Gynecol Cancer 18 2008 414 420
14. S.S. Buys, E. Partridge, M.H. Greene, P.C. Prorok, D. Reding, and T.L. Riley Ovarian cancer screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening trial: findings from the initial screen of a randomized trial Am J Obstet Gynecol 193 2005 1630 1639
15. E. Partridge, A.R. Kreimer, R.T. Greenlee, C. Williams, J.L. Xu, and T.R. Church Results from four rounds of ovarian cancer screening in a randomized trial Obstet Gynecol 113 2009 775 782
16. U. Menon, A. Gentry-Maharaj, R. Hallett, A. Ryan, M. Burnell, and A. Sharma Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS) Lancet Oncol 10 2009 327 340
17. The Cochrane Collaboration Cochrane Handbook for Systematic Reviews of Interventions (Version 5.0.2) 2009 Cochrane Collaboration Oxford
18. G.H. Guyatt, A.D. Oxman, G.E. Vist, R. Kunz, Y. Falck-Ytter, and P. Alonso-Coello GRADE: an emerging consensus on rating quality of evidence and strength of recommendations BMJ 336 2008 924 926
19. D. Atkins, D. Best, P.A. Briss, M. Eccles, Y. Falck-Ytter, and S. Flottorp Grading quality of evidence and strength of recommendations BMJ 328 2004 1490
20. Cochran IMS. GradePro. http://ims.cochrane.org/gradepro.
21. B. Tendal, E. Nuesch, J.P. Higgins, P. Juni, and P.C. Gotzsche Multiplicity of data in trial reports and the reliability of meta-analyses: empirical study BMJ 343 2011 d4829
22. N. Lalwani, A.K. Shanbhogue, R. Vikram, A. Nagar, J. Jagirdar, and S.R. Prasad Current update on borderline ovarian neoplasms AJR Am J Roentgenol 194 2010 330 336
23. M.F. Freeman, and J.W. Tukey Transformations related to the angular and the square root Ann Math Stat 21 1950 607 611
24. J.J. Miller The inverse of the Freeman-Tukey double arcsine transformation Am Stat 32 1978 138
25. C.A. Parkes, D. Smith, N.J. Wald, and T.H. Bourne Feasibility study of a randomised trial of ovarian cancer screening among the general population J Med Screen 1 1994 209 214
26. A. Tabor, F.R. Jensen, J.E. Bock, and C.K. Hogdall Feasibility study of a randomised trial of ovarian cancer screening J Med Screen 1 1994 215 219
27. I.J. Jacobs, S.J. Skates, N. Macdonald, U. Menon, A.N. Rosenthal, and A.P. Davies Screening for ovarian cancer: a pilot randomised controlled trial Lancet 353 1999 1207 1210
28. K.L. Taylor, R. Shelby, E. Gelmann, and C. McGuire Quality of life and trial adherence among participants in the prostate, lung, colorectal, and ovarian cancer screening trial J Natl Cancer Inst 96 2004 1083 1094
29. U. Menon, S.J. Skates, S. Lewis, A.N. Rosenthal, B. Rufford, and K. Sibley Prospective study using the risk of ovarian cancer algorithm to screen for ovarian cancer J Clin Oncol 23 2005 7919 7926
30. D.B. Johnson The effects of an abnormal cancer screening test on health related quality of life Int J Cancer Res 2 2006 277 289
31. M.R. Andersen, C.W. Drescher, Y. Zheng, D.J. Bowen, S. Wilson, and A. Young Changes in cancer worry associated with participation in ovarian cancer screening Psychooncology 16 2007 814 820
32. M. Horowitz, N. Wilner, and W. Alvarez Impact of Event Scale: a measure of subjective stress Psychosom Med 41 1979 209 218
33. X. Sun, M. Briel, J.W. Busse, J.J. You, E.A. Akl, and F. Mejza Credibility of claims of subgroup effects in randomised controlled trials: systematic review BMJ 344 2012 e1553
34. E.J. Pavlik, and J.R. van Nagell Jr. Ovarian cancer screening - what women want Int J Gynecol Cancer 22 Suppl. 1 2012 S21 S23
35. D.L. Sackett The arrogance of preventive medicine CMAJ 167 2002 363 364
36. L. Gilbert, O. Basso, J. Sampalis, I. Karp, C. Martins, and J. Feng Assessment of symptomatic women for early diagnosis of ovarian cancer: results from the prospective DOvE pilot project Lancet Oncol 13 2012 285 291
37. A. Gentry-Maharaj, J. Kalsi, M. Burnell, R. Manchanda, and U. Menon Screening of symptomatic women for ovarian cancer Lancet Oncol 13 2012 e138 e139
38. A.A. Tone, D.G. Huntsman, and D.M. Miller Screening of symptomatic women for ovarian cancer Lancet Oncol 13 2012 e137 e138
39. B. Rosen, J. Kwon, M. Fung Kee Fung, and A. Gagliardi Members of the Gynecology Cancer Disease Site Group. Management options for women with a hereditary predisposition to ovarian cancer. Program in evidence-based care Cancer Care Ont 2004 Evidence Summary Report 4-4. Accessed Dec 17, 2012. https://www.cancercare.on.ca/common/pages/UserFile.aspx?fileId=34205.
40. ACOG Practice Bulletin No. 89. Elective and risk-reducing salpingo-oophorectomy Obstet Gynecol 111 2008 231 241
41. ACOG Hereditary breast and ovarian cancer syndrome ACOG practice bulletin 2009 American College of Obstetricians and Gynecologists Washington, DC
42. J. Carlson, A. Miron, E. Jarboe, M. Parast, M. Hirsch, and Y. Lee Serous tubal intraepithelial carcinoma: its potential role in primary peritoneal serous carcinoma and serous cancer prevention J Clin Oncol 26 2008 4160 4165
43. Y. Lee, A. Miron, R. Drapkin, M.R. Nucci, F. Medeiros, and A. Saleemuddin A candidate precursor to serous carcinoma that originates in the distal fallopian tube J Pathol 211 2007 26 35
44. F.M.D. Medeiros, M.G.M.D. Muto, Y.M.D. Lee, J.A.M.D.P. Elvin, M.J.M.D. Callahan, and C.M.D. Feltmate The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome Am J Surg Pathol 30 2006 230 236
45. S. Tang, K. Onuma, P. Deb, E. Wang, A. Lytwyn, and M. Sur Frequency of serous tubal intraepithelial carcinoma in various gynecologic malignancies: a study of 300 consecutive cases Int J Gynecol Pathol 31 2012 103 110
46. D.W.M.D. Kindelberger, Y.M.D. Lee, A.P. Miron, M.S.M.D.P. Hirsch, C.M.D. Feltmate, and F.M.D. Medeiros Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: evidence for a causal relationship Am J Surg Pathol 31 2007 161 169
47. S.N. Agoff, J.E. Mendelin, V.S. Grieco, and R.L. Garcia Unexpected gynecologic neoplasms in patients with proven or suspected BRCA-1 or -2 mutations: implications for gross examination, cytology, and clinical follow-up Am J Surg Pathol 26 2002 171 178
48. C.J. Reade, S. Finlayson, J. McAlpine, A.A. Tone, M. Fung Kee Fung, and S.E. Ferguson Risk-reducing salpingectomy in Canada: a survey of obstetrician-gynaecologists J Obstet Gynaecol Can 35 2013 627 634